423 related articles for article (PubMed ID: 25894244)
1. Occluded Tunneled Venous Catheter in Hemodialysis Patients: Risk Factors and Efficacy of Alteplase.
Ponce D; Mendes M; Silva T; Oliveira R
Artif Organs; 2015 Sep; 39(9):741-7. PubMed ID: 25894244
[TBL] [Abstract][Full Text] [Related]
2. Effective use of alteplase for occluded tunneled venous catheter in hemodialysis patients.
Mendes ML; Castro JH; Silva TN; Barretti P; Ponce D
Artif Organs; 2014 May; 38(5):399-403. PubMed ID: 24117542
[TBL] [Abstract][Full Text] [Related]
3. Alteplase vs. urokinase for occluded hemodialysis catheter: A randomized trial.
Pollo V; Dionízio D; Bucuvic EM; Castro JH; Ponce D
Hemodial Int; 2016 Jul; 20(3):378-84. PubMed ID: 26851872
[TBL] [Abstract][Full Text] [Related]
4. Alteplase for the treatment of catheter occlusion in pediatric patients.
Anderson DM; Pesaturo KA; Casavant J; Ramsey EZ
Ann Pharmacother; 2013 Mar; 47(3):405-9. PubMed ID: 23463740
[TBL] [Abstract][Full Text] [Related]
5. [Access for starting kidney replacement therapy: vascular and peritoneal temporal access in pre-dialysis].
Rodríguez CR; Bardón Otero E; Vila Paz ML
Nefrologia; 2008; 28 Suppl 3():105-12. PubMed ID: 19018747
[TBL] [Abstract][Full Text] [Related]
6. A longitudinal study of the repeated use of alteplase as therapy for tunneled hemodialysis catheter dysfunction.
Little MA; Walshe JJ
Am J Kidney Dis; 2002 Jan; 39(1):86-91. PubMed ID: 11774106
[TBL] [Abstract][Full Text] [Related]
7. Reduction in catheter-related infections after switching from povidone-iodine to chlorhexidine for the exit-site care of tunneled central venous catheters in children on hemodialysis.
Paglialonga F; Consolo S; Biasuzzi A; Assomou J; Gattarello E; Patricelli MG; Giannini A; Chidini G; Napolitano L; Edefonti A
Hemodial Int; 2014 Oct; 18 Suppl 1():S13-8. PubMed ID: 25330826
[TBL] [Abstract][Full Text] [Related]
8. Complications From Tunneled Hemodialysis Catheters: A Canadian Observational Cohort Study.
Poinen K; Quinn RR; Clarke A; Ravani P; Hiremath S; Miller LM; Blake PG; Oliver MJ
Am J Kidney Dis; 2019 Apr; 73(4):467-475. PubMed ID: 30642607
[TBL] [Abstract][Full Text] [Related]
9. Recombinant tissue plasminogen activator (alteplase) for restoration of function to occluded central venous catheters in pediatric patients.
Shen V; Li X; Murdock M; Resnansky L; McCluskey ER; Semba CP;
J Pediatr Hematol Oncol; 2003 Jan; 25(1):38-45. PubMed ID: 12544772
[TBL] [Abstract][Full Text] [Related]
10. Which central venous catheters have the highest rate of catheter-associated deep venous thrombosis: a prospective analysis of 2,128 catheter days in the surgical intensive care unit.
Malinoski D; Ewing T; Bhakta A; Schutz R; Imayanagita B; Casas T; Woo N; Margulies D; Barrios C; Lekawa M; Chung R; Bukur M; Kong A
J Trauma Acute Care Surg; 2013 Feb; 74(2):454-60; discussion 461-2. PubMed ID: 23354238
[TBL] [Abstract][Full Text] [Related]
11. Alteplase versus urokinase for occluded hemodialysis catheters.
Zacharias JM; Weatherston CP; Spewak CR; Vercaigne LM
Ann Pharmacother; 2003 Jan; 37(1):27-33. PubMed ID: 12503929
[TBL] [Abstract][Full Text] [Related]
12. Alteplase for the treatment of central venous catheter occlusion in children: results of a prospective, open-label, single-arm study (The Cathflo Activase Pediatric Study).
Blaney M; Shen V; Kerner JA; Jacobs BR; Gray S; Armfield J; Semba CP;
J Vasc Interv Radiol; 2006 Nov; 17(11 Pt 1):1745-51. PubMed ID: 17142704
[TBL] [Abstract][Full Text] [Related]
13. Cefazolin-gentamicin versus taurolidine-citrate for the prevention of infection in tunneled central catheters in hemodialysis patients: A quasi-experimental trial.
Bueloni TNV; Marchi D; Caetano C; de Souza Cavalcante R; Mendes Amaral ML; Ponce D
Int J Infect Dis; 2019 Aug; 85():16-21. PubMed ID: 31102823
[TBL] [Abstract][Full Text] [Related]
14. Need for tissue plasminogen activator for central venous catheter dysfunction is significantly associated with thrombosis in pediatric cancer patients.
MacLean J; MacDonald T; Digout C; Smith N; Rigby K; Kulkarni K
Pediatr Blood Cancer; 2018 Jun; 65(6):e27015. PubMed ID: 29537717
[TBL] [Abstract][Full Text] [Related]
15. Thrombolysis with alteplase: a non-invasive treatment for occluded arteriovenous fistulas and grafts.
Tseke P; Kalyveza E; Politis E; Giapraka N; Andriopoulos C; Balitsari A; Papatzikos L; Stavgianoudakis G
Artif Organs; 2011 Jan; 35(1):58-62. PubMed ID: 20626738
[TBL] [Abstract][Full Text] [Related]
16. Externalization of tunneled hemodialysis catheter in patients with tunnel or exit-site infections and limited access options.
Jaberi A; Hadziomerovic A; Toor SS; Galwa RP; Graham J; Thornhill RE; Ryan SE
J Vasc Interv Radiol; 2014 Apr; 25(4):561-6. PubMed ID: 24674214
[TBL] [Abstract][Full Text] [Related]
17. Tenecteplase in the treatment of thrombosed hemodialysis grafts.
Falk A; Harbour K
Cardiovasc Intervent Radiol; 2005; 28(4):472-5. PubMed ID: 16001142
[TBL] [Abstract][Full Text] [Related]
18. Comparison of alteplase and urokinase for pharmacomechanical thrombolysis of clotted hemodialysis access.
Tan RY; Pang SC; Teh SP; Lee KG; Chong TT; Gogna A; Tan CS
J Vasc Access; 2019 Sep; 20(5):501-506. PubMed ID: 30585114
[TBL] [Abstract][Full Text] [Related]
19. Arteriovenous grafts are associated with earlier catheter removal and fewer catheter days in the United States Renal Data System population.
Leake AE; Yuo TH; Wu T; Fish L; Dillavou ED; Chaer RA; Leers SA; Makaroun MS
J Vasc Surg; 2015 Jul; 62(1):123-7. PubMed ID: 25769391
[TBL] [Abstract][Full Text] [Related]
20. Tissue plasminogen activator as a hemodialysis catheter locking solution.
McGill RL; Spero JA; Sysak JC; Sandroni SE; Marcus RJ
Hemodial Int; 2008 Jul; 12(3):348-51. PubMed ID: 18638092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
